AORT
Artivion Inc
NYSE: AORT · HEALTHCARE · MEDICAL DEVICES
$26.17
-2.71% today
Updated 2026-08-05
Market cap
$1.30B
P/E ratio
107.32
P/S ratio
2.84x
EPS (TTM)
$0.25
Dividend yield
—
52W range
$19 – $48
Volume
0.7M
Artivion Inc (AORT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$26.17
12-Month target
$1.43
2030 Target
—
Intrinsic (DCF)
$30.26
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.3B | $0.3B | $0.4B | $0.4B | $0.4B | $0.5B | $0.6B | $0.6B | $0.7B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 11.75% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 2.55%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.